Allegheny Health and Wellness Pavilion

Erie, Pennsylvania 16506

2 studies enrolling now · 14 studies all time

What they study most

COVID-19, Lyme Borreliosis, Lyme Disease, Maternal Immunization, Pneumococcal Disease, Pneumococcal Infections, Pneumococcal Vaccines, Respiratory Tract Infection, SARS-CoV-2 Infection, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2

Studies at this site

• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants. — Recruiting now
• A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine — Recruiting now
• A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children — Completed
• A Study to Learn About How a New Pneumococcal Vaccine Works in Infants — Running, not enrolling
• An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
• Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population — Completed
• Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children — Completed
• Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants — Completed
• A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. — Completed
• To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older — Completed
• Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants — Stopped early
• Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants — Completed